| |
Newsroom /
Technology
/
Electronics
/
Isansys Launch LifeTouch Multi-function Body Monitor
Isansys Launch LifeTouch Multi-function Body Monitor
The latest addition to IsansysLifecare’s wireless physiological monitoring platform for the delivery of continuous, real-time patient data to healthcare professionals
Reading,
Berkshire,
United Kingdom
(prbd.net)
10/05/2011
Abingdon, United Kingdom, 10th May 2011 – IsansysLifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces the launch of the LifeTouch HRV011 a radical new addition to its Lifecare Platform. The LifeTouch is an intelligent cardiac monitor that adheres to the patient’s body and analyses the ECG signal of every heartbeat. Key physiological parameters, including heart rate, respiration rate and high resolution QRS intervals are calculated and uploaded from the LifeTouch to the secure HL7 compliant database in the IsansysLifecare Platform – a multi layer, configurable, fully scalable, wireless patient monitoring platform. IsansysLifecare’s services, tailored to meet the individual requirements of the care provider, are built on the Lifecare Platform, which is available now.
Resembling a lightweight adhesive bandage strip, the LifeTouch HRV011 is simple to fit, unobtrusively attaches to the body and is comfortable to wear. It continuously measures and digitises the ECG signal at a rate four to five times greater than the standard required for ECG monitors thus offering unprecedented scope for a range of new analytical techniques and algorithms that can run in the HRV011 itself on the advanced ultra-low power integrated microprocessor. Current functions include heart rate, respiration rate, high-resolution QRS intervals and other heart rate variability parameters that are used, among other things, to derive the respiration rate using Isansys’ multi-parameter LifeBreath algorithm. Fundamental or derived data (or both) are sent to the web-based database where it can be stored and integrated with other patient information, or forwarded and accessed only by authorized users. Further analysis can be carried out on the data in the database to provide more information about the patient such as indicators of stress and health-warning scores and used to generate alerts or prompts regarding status of the patient.
The LifeTouch HRV011 is built on the Isansys RK001 sensing platform that brings a new level of local intelligence to body worn devices by means of a new, very low power ARM Cortex based microcontroller. The wireless link uses the well-proven ANT ultra-low power wireless protocol. These inherently low power consumption components, together with efficient algorithms provide a continuous working lifetime of up to 100 hours.
Uniquely, the LifeTouch is a semi-disposable hybrid developed with support from Scapa Medical division of Scapa plc, global producers of specialist skin friendly adhesive tape solutions. From the users’ point of view it is a single use device. However, a key element of the Isansys service model is a recycling service that recovers, sterilises and refurbishes the electronic module (including the battery), disposes of and replaces the medical grade laminate materials that form the substrate and enclosure for the electronic module, before re-testing and re-packaging for subsequent re-use. This unique service approach ensures all the benefits of fully disposable devices whilst maintaining compliance with the EU WEEE directive and adherence to good environmental practice and substantially reduces the effective cost of the LifeTouch devices.
Scapa’s Medical Business Unit and Specialist Conversion Team are utilising their expertise in skin-friendly solutions and design and prototyping to support Isansys in the early stages of the development of the LifeTouch. Mr Barry Andrew, Global Medical Business Unit Director, commented “We are very proud to be involved with the development and launch of the LifeTouch. This new, exciting technology epitomises Scapa’s dedication to offering turnkey solutions for the future Medical environment” Scapa’s development team continues to be highly motivated by this project and looks forward to working with IsansysLifecare on the introduction of this device.
Commenting on the launch of LifeTouch, IsansysLifecare CEO Keith Errey said: “This is an exciting time for Isansys to be able to offer a device and service to the healthcare market that is not openly and readily available anywhere else in the world.” He continues “The addition of LifeTouch to the IsansysLifecare Platform provides healthcare professionals with a fantastic new tool for the provision of continuous and real-time patient information. The power of our Lifecare Platform is that this information can be delivered in a customised form from a secure database to an authorised care provider anywhere. For patients we are introducing a fuss-free, unobtrusive device that may be worn under clothing and requires no adjustment, calibration, recharging or battery changing. For the environment we are introducing a near zero impact device with all the benefits of a disposable. We think this is a really important and necessary product.”
IsansysLifecare Business Development Director, Rebecca Weir said: “We recognised that the first requirement is to work with leading and visionary clinicians to help them generate the evidence and experience base relevant to their own specialities and organisations. To do this we offer a service that overcomes the problems of technology and up-front capital investment, providing the focus, support and resource necessary to run an efficient and influential clinical study or pilot project.” Rebecca added “We also recognised that these leading clinicians wanted to get to work NOW, in order to develop their own areas of research and address the current needs of their patients and we have worked hard to build our services and technology in order to help them TODAY.”
###
About IsansysLifecare Limited (http://www.isansys.com)
IsansysLifecare is the easy, fast and secure way to new physiological information and clinical insights for better care and improved patient safety.
We work with leading healthcare professionals, institutes and policy organisations operating in a wide range of healthcare settings, who want to employ new patient monitoring technologies and methods to improve patient outcomes and reduce costs.
With comprehensive industry knowledge and the essential technical, clinical and regulatory expertise, Isansys is able to manage the entire process and provide a complete service, focusing on:
• enhancing the relationship between patient and physician
• providing a complete end-to-end system – the IsansysLifecare Platform – to continuously and wirelessly capture, collect, interpret and securely store vital sign and other physiological patient data. An inherent part of our Platform is a dedicated, world-class team of engineers, mathematicians, physiologists and clinicians.
• offering secure, authorised access to this data on any remote device including desktop, laptop or tablet computer or smart phone.
• generating clinically validated and relevant information in simple usable formats, not columns of numbers or multiple confusing charts. Where appropriate or required, this data is integrated into the clients’ electronic health record system.
• enabling clients to harness the Platform to generate the evidence base necessary to validate clinical and economic outcomes, from proof-of-concept studies and demonstration projects to full large scale system roll out and implementations
About Continuous Patient Physiological Monitoring
It is well documented that patients who deteriorate and require admission to critical care or who suffer cardiac arrest, or many other adverse conditions, have abnormalities that are detectable by physiological observations well in advance. Continuous (or nearly continuous) monitoring of multiple vital signs provides the fundamental input for improved patient outcomes and reduced overall costs. In the US alone, remote patient monitoring devices are forecast to reduce healthcare costs by nearly $200 billion during the next 25 years, if more widely used by patients with certain chronic diseases (Source: Center for Technol
About
NeonDrum is a targeted global online news release distribution and monitoring service for PR professionals.
Our mission is simple: to boost online coverage of your B2B press releases, help you to punch above your weight in the online channel, and get you seen, heard - and found - by the people that matter
|